While the number of COVID-19 cases across the country is decreasing, pediatricians at Monroe Carell Jr. Children’s Hospital at Vanderbilt are beginning to see a new post-surge trend: an increase
AllStripes Announces Rare Disease Research Expansion into the United Kingdom
AllStripes approved to conduct research with patients residing in England, Scotland, Wales and Northern Ireland
AllStripes, a healthcare technology company dedicated to accelerating treatment research for patients with rare diseases, today announced it is expanding its rare disease research efforts into the United Kingdom. This is the company s first major expansion outside of North America AllStripes currently conducts research in the United States and Canada and represents a significant milestone for the rare disease community in the U.K. AllStripes seeks to utilize its cutting-edge technology to analyze community data to improve clinical trial design, and ultimately unlock new treatments that improve quality of life.